General Introduction to QSAR
暂无分享,去创建一个
[1] E. C. Herrmann,et al. Computer Aided Drug Design in Industrial Research , 1995, Ernst Schering Research Foundation Workshop.
[2] Han van de Waterbeemd,et al. Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric , 1995 .
[3] Michael Wiese,et al. Drug-membrane interactions : analysis, drug distribution, modeling , 2002 .
[4] G. Cruciani,et al. Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .
[5] C. Hansch,et al. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .
[6] I V Tetko,et al. Volume learning algorithm artificial neural networks for 3D QSAR studies. , 2001, Journal of medicinal chemistry.
[7] H. Kubinyi. QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .
[8] H. Kubinyi,et al. 3D QSAR in drug design. , 2002 .
[9] S. Free,et al. A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.
[10] Gabriele Cruciani,et al. GOLPE-Guided Region Selection , 1998 .
[11] J. Topliss,et al. Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.
[12] James W. McFarland,et al. On Identifying Likely Determinants of Biological Activity in High Dimensional QSAR Problems , 1994 .
[13] A. Leo. CALCULATING LOG POCT FROM STRUCTURES , 1993 .
[14] Anton J. Hopfinger,et al. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..
[15] P. N. Craig,et al. Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarials. , 1979, Journal of medicinal chemistry.
[16] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[17] Gabriele Cruciani,et al. A New Set of Principal Properties for Heteroaromatics Obtained by GRID , 1996 .
[18] Daniel E. Platt,et al. Comparative molecular moment analysis (CoMMA) , 1998 .
[19] David E. Leahy,et al. Model solvent systems for QSAR. Part 3. An LSER analysis of the ‘critical quartet.’ New light on hydrogen bond strength and directionality , 1992 .
[20] Ulf Norinder,et al. Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..
[21] G. Klopman. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .
[22] Han van de Waterbeemd,et al. Computer-Assisted Lead Finding and Optimization , 1997 .
[23] Corwin Hansch,et al. Comparative QSAR: Toward a Deeper Understanding of Chemicobiological Interactions. , 1996, Chemical reviews.
[24] E. Möller. Chemische Struktur und biologische Aktivität von Wirkstoffen. Methoden der Quantitativen Struktur‐Wirkung‐Analyse. Von J. K. Seydel und K.‐J. Schaper. Verlag Chemie, Weinheim 1979. XI, 359 S., geb. DM 118.00 , 1980 .
[25] Ulf Norinder,et al. Recent Progress in CoMFA Methodology and Related Techniques , 1998 .
[26] H. Kubinyi. QSAR : Hansch analysis and related approaches , 1993 .
[27] Toshio Fujita,et al. Classical and Three-Dimensional QSAR in Agrochemistry , 1995 .
[28] Robert Bywater,et al. Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..
[29] M. Feher,et al. A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.
[30] Rainer Franke,et al. Topological Pharmacophores New Methods and Their Application to a Set of Antimalarials Part 1: The Methods LOGANA and LOCON , 1985 .
[31] S. Wold,et al. PLS: Partial Least Squares Projections to Latent Structures , 1993 .
[32] Variable selection in PLS analysis , 1993 .
[33] A. Leo,et al. Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. , 2002, Chemical reviews.
[34] Svante Wold,et al. D-Optimal Designs in QSAR , 1993 .
[35] Corwin Hansch,et al. A survey of Hammett substituent constants and resonance and field parameters , 1991 .
[36] A. Hopfinger. A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis , 1980 .
[37] Y. Martin,et al. Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics. , 1971, Journal of medicinal chemistry.
[38] R. Franke,et al. EVAL — A New Tool to Evaluate Topological Pharmacophores , 1991 .
[39] H S Rosenkranz,et al. Toxicity estimation by chemical substructure analysis: the TOX II program. , 1995, Toxicology letters.
[40] Gerd Folkers,et al. Pharmacokinetic optimization in drug research , 2001 .
[41] Vladimir Poroikov,et al. Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, J. Chem. Inf. Comput. Sci..
[42] Gerhard Klebe,et al. Comparative Molecular Similarity Indices Analysis: CoMSIA , 1998 .
[43] V. Kulkarni,et al. Multiple Regression and Principal Component Analysis of Antibacterial Activities of Sulfones and Sulfonamides in Whole Cell and Cell-Free Systems of Various DDS Sensitive and Resistant Bacterial Strains , 1985 .
[44] Vladimir Poroikov,et al. Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors , 1999, J. Chem. Inf. Comput. Sci..
[45] Nenad Trinajstic,et al. Nonlinear Multivariate Regression Outperforms Several Concisely Designed Neural Networks on Three QSPR Data Sets , 2000, J. Chem. Inf. Comput. Sci..
[46] Gabriele Cruciani,et al. Principal Properties for Aromatic Substituents. A Multivariate Approach for Design in QSAR , 1989 .
[47] C. Hansch,et al. Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. , 2001, Chemical reviews.
[48] Nenad Trinajstic,et al. Multivariate Regression Outperforms Several Robust Architectures of Neural Networks in QSAR Modeling , 1999, J. Chem. Inf. Comput. Sci..
[49] Yvonne C. Martin,et al. 3D QSAR: current state, scope, and limitations , 1998 .
[50] Hxugo Kubiny. Variable Selection in QSAR Studies. I. An Evolutionary Algorithm , 1994 .
[51] Han van de Waterbeemd,et al. Lipophilicity in Drug Action and Toxicology: Pliška/Lipophilicity , 1996 .
[52] Jens Sadowski,et al. The Use of Self-organizing Neural Networks in Drug Design , 2002 .
[53] Corwin Hansch,et al. Role of hydrophobic effects in mechanistic QSAR , 1999 .